Bariatric Device

Medical Informatics News

Medical Informatics RSS Feed

RSS Feeds

Advertise

 

            Home | News | White Papers | Buyer's Guide  

Industry Highlights

 Informatics White Papers

Informatics Market Reports

Informatics Buyer's Guide

Informatics Training

Informatics Resources

 

Informatics News

Informatics Press Releases

Informatics RSS Feeds

Informatics Company List

Informatics Events

Informatics Stocks

Informatics Books

 Informatics Jobs
 
 

 Bariatric Device

 
Leader Emerges in Bariatric Device Race

Other Topics: Online Clinical Reference Tool, Memory Assessment Technology

PRNewswire
May 2, 2007

Atlanta, GA -- Forty-nine percent of the people using a simple new medical device lost more than 5 percent of their body weight in four months vs. 4.5 percent of a comparable control group who did not use the device according to a newly-completed clinical trial announced today by Scientific Intake. These study results exceeded the primary endpoint and the company plans to submit the data with its application for FDA approval in May.

The study was conducted in people who were overweight to obese, with a Body Mass Index of 27 to 35kg/m2. Scientific Intake's broadly patented device is the only approach to obesity utilizing dietary restriction at the oral cavity where food enters the body vs. restriction in the gut with surgery.
 

 
By simulating Torus Palatinus, a condition found in nature and common among thin people, the device displaces volume in the palatal vault. This enhances savoring, precludes food gulping and slows food intake, thereby allowing satiety signals to trigger on smaller amounts of food. The intended result is that users feel satisfied on less food.

Highlights of the study were as follows:
  • 48.78% of the device group lost 5% or more of their total body weight
  • 4.48% of the control group lost 5% or more of their body weight
  • The difference in success rates between device and control groups was
    statistically significant with a P value of < .0001

The 174 patient, prospective, randomized study, conducted at five clinical centers in the U.S. over a four month period will be submitted to the Food and Drug Administration (FDA) in May as part of an application
seeking 510(k) clearance for the Scientific Intake Device(TM). The device has already been designated by FDA as non-significant risk.

The IRB approved study was conducted in accordance with the FDA's Investigational Device Exemption (IDE) regulations. The custom made Scientific Intake Device(TM) will be made individually for each patient from medical grade acrylic with soft edges and nitonal-like clasps. The device is designed to fit comfortably during eating and to be easily and quickly inserted and removed.

Scientific Intake's proprietary "Compliance Microsensor" embedded in each device plays a key role in remote monitoring while providing user friendly medical informatics that both patients and physicians can
interpret at a glance. Mitchell Roslin M.D., F.A.C.S., Chief of Obesity Surgery at New York's Lenox Hill Hospital and Chief Medical Officer at Scientific Intake comments:

"These results are superior to weight loss achieved by pharmaceutical therapies with none of the unpredictable, unpleasant side effects. These data add to the growing body of science linking rate of food intake to satiety signals and excess caloric consumption.

"Devices that force people to eat less have all focused on the stomach. We now have data that shows limiting food intake at the oral cavity, a far more accessible part of the human body, can be used to treat patients ranging from overweight to morbidly obese. This predicate device can serve as a template for a variety of future oral interventions."

William Longley, CEO of Scientific Intake, added "According to this study, we clearly exceeded the endpoint of showing increased weight loss in patients using the device as compared to the control group. We are excited about our potential to make a real difference in the obesity epidemic and are hopeful that our 510(k) submission will be satisfactory to FDA so that Scientific Intake can begin playing a major role in a healthier America. Our broad IP portfolio and product pipeline covering all aspects of dietary restriction at the point where food enters the body will be investigated in future studies."

The study began February 9, 2006 and was run by Alquest, Inc., a contract research organization based in Minneapolis, Minnesota. The clinical trial results confirm previous studies with the Scientific Intake Device(TM). In one study, conducted at The Pennington Biomedical Research Center at Louisiana State University and published in the peer reviewed journal Obesity Research in November 2004, food intake of
thirty-two overweight participants was monitored for two days. The food intake of the subjects using the Scientific Intake Device(TM) was 23% less than participants not using the device.

Longer term case studies from research performed in Atlanta, Knoxville, and Detroit showed similar results. Twenty-four subjects were initially weighed and fitted for a device. After 30 days of using the device, the
average weight loss average for all subjects was 5.88 pounds. Medical research has shown that satiety is gradually reached long after most adults have finished eating. Once the satiety signal has been received, the desire to consume additional food is greatly diminished. The theory behind the Scientific Intake Device(TM) is that if ingestion of food occurred more slowly, the satiety signal would be initiated and received prior to the consumption of unnecessary additional amounts of food. One way to encourage slower eating is to reduce the size of bites of food with the introduction of a device that decreases oral capacity by displacing area in the palatal vault. This causes slower intake and more thorough, longer chewing times.

The Scientific Intake Device(TM) is investigational and not currently approved for sale in the U.S.

 
 

Home

White Papers Equipment Company List Market Reports RSS Feeds Training Advertise Contact Us
© 2007 Medical Informatics News, All Rights Reserved Worldwide